BioInvent International AB (publ)

Stockholm Stock Exchange:BINV.ST

Location

Market Cap

USD 283.88 M

Share Price

USD 4.31

Avg Daily Volume

98,878

Change (1 day)

2.50%

Change (1 year)

12.72%

Change (YTD)

24.09%

BioInvent International AB (publ) EBIT Margin for the year ending December 31, 2024: -959.33%

BioInvent International AB (publ) EBIT Margin is -959.33% for the year ending December 31, 2024, a 108.08% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • BioInvent International AB (publ) EBIT Margin for the year ending December 31, 2023 was -461.04%, a 3,492.49% change year over year.
  • BioInvent International AB (publ) EBIT Margin for the year ending December 31, 2022 was -12.83%, a -99.10% change year over year.
  • BioInvent International AB (publ) EBIT Margin for the year ending December 31, 2021 was -1,433.80%, a 2,680.39% change year over year.
  • BioInvent International AB (publ) EBIT Margin for the year ending December 31, 2020 was -51.57%, a -65.01% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin